Alikhan Raza, Cohen Alexander T, Combe Sophie, Samama Meyer M, Desjardins Louis, Eldor Amiram, Janbon Charles, Leizorovicz Alain, Olsson Carl-Gustav, Turpie Alexander G G
Academic Department of Surgery, Guy's, King's, and St Thomas' School of Medicine, London, England.
Arch Intern Med. 2004 May 10;164(9):963-8. doi: 10.1001/archinte.164.9.963.
There is limited information about risk factors for venous thromboembolism (VTE) in acutely ill hospitalized general medical patients.
An international, randomized, double-masked, placebo-controlled trial (MEDENOX) has previously been conducted in 1102 acutely ill, immobilized general medical patients and has shown the efficacy of using a low-molecular-weight heparin, enoxaparin sodium, in preventing thrombosis. We performed logistic regression analysis to evaluate the independent nature of different types of acute medical illness (heart failure, respiratory failure, infection, rheumatic disorder, and inflammatory bowel disease) and predefined factors (chronic heart and respiratory failure, age, previous VTE, and cancer) as risk factors for VTE.
The primary univariate analysis showed that the presence of an acute infectious disease, age older than 75 years, cancer, and a history of VTE were statistically significantly associated with an increased VTE risk. Multiple logistic regression analysis indicated that these factors were independently associated with VTE.
Several independent risk factors for VTE were identified. These findings allow recognition of individuals at increased risk of VTE and will contribute to the formulation of an evidence-based risk assessment model for thromboprophylaxis in hospitalized general medical patients.
关于急性病住院普通内科患者静脉血栓栓塞症(VTE)危险因素的信息有限。
此前在1102例急性病、活动受限的普通内科患者中进行了一项国际、随机、双盲、安慰剂对照试验(MEDENOX),结果显示使用低分子量肝素依诺肝素钠预防血栓形成有效。我们进行了逻辑回归分析,以评估不同类型的急性内科疾病(心力衰竭、呼吸衰竭、感染、风湿性疾病和炎症性肠病)以及预定义因素(慢性心力衰竭和呼吸衰竭、年龄、既往VTE病史和癌症)作为VTE危险因素的独立性。
单因素分析初步显示,急性传染病、年龄大于75岁、癌症以及VTE病史与VTE风险增加在统计学上显著相关。多因素逻辑回归分析表明,这些因素与VTE独立相关。
确定了几个VTE的独立危险因素。这些发现有助于识别VTE风险增加的个体,并将有助于制定基于证据的住院普通内科患者血栓预防风险评估模型。